Azithromycin (ophthalmic): Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 17: | Line 17: | ||
'''| [[Azithromycin warnings and precautions|Warnings and Precautions]]''' | '''| [[Azithromycin warnings and precautions|Warnings and Precautions]]''' | ||
'''| [[Azithromycin adverse reactions|Adverse Reactions]]''' | '''| [[Azithromycin adverse reactions|Adverse Reactions]]''' | ||
'''| [[Azithromycin clinical studies|Clinical Studies]]''' | '''| [[Azithromycin clinical studies|Clinical Studies]]''' | ||
'''| [[Azithromycin dosage and administration|Dosage and Administration]]''' | '''| [[Azithromycin dosage and administration|Dosage and Administration]]''' | ||
'''| [[Azithromycin compatibility reconstitution and stability|Compatibility, Reconstitution, and Stability]]''' | '''| [[Azithromycin compatibility reconstitution and stability|Compatibility, Reconstitution, and Stability]]''' | ||
'''| [[Azithromycin how supplied|How Supplied]]''' | '''| [[Azithromycin how supplied|How Supplied]]''' | ||
'''| [[Azithromycin labels and packages|Labels and Packages]]''' | '''| [[Azithromycin labels and packages|Labels and Packages]]''' | ||
Revision as of 18:45, 30 December 2013
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Category
US Brand Names
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Clinical Studies | Dosage and Administration | Compatibility, Reconstitution, and Stability | How Supplied | Labels and Packages